Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Study Identifier
192024-063
CT.gov Identifier
NCT01241240
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Ocular Hypertension
    • Study Drug
  • bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy)
  • Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Ocular hypertension or primary open-angle glaucoma in each eye * Requires treatment with IOP-lowering medication in both eyes
    Exclusion Criteria:
    * Required chronic use of ocular medications during the study other than study medication * Use of any corticosteroids within 30 days * History of any prior eye surgery, except for uncomplicated eye surgery performed more than 6 months before the Screening visit * Anticipated wearing of contact lenses during the study

    Protocol Summary

    This study will evaluate the safety and efficacy of Triple Combination Therapy compared with Fixed Combination brimonidine tartrate/timolol ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension.

    Study Locations

    Location
    Status
    Location
    Bogotá, Colombia
    Status
    Not applicable
    Location
    Mexico City, Mexico
    Status
    Not applicable